News
4317 posts · page 39 of 180
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Following IPO
Molbio Diagnostics swings to Rs 52.7 crore profit in Q1, driven by increased Truenat test-kit sales post-IPO.
Medtronic Raises Fiscal 2027 Forecasts Amid Heart Device Surge
Medtronic ups fiscal 2027 projections on rising heart device demand, investing in Pi-Cardia and Cornerstone Robotics.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 Following IPO
Molbio Diagnostics posted a Rs 52.7 crore profit in Q1, reversing last year's loss, due to increased Truenat test-kit sales.
Gen-Z Embraces 'Wellness Darties' for Sober College Events
College students are turning to 'wellness darties' featuring pilates and saunas, signaling a shift away from traditional alcohol-fueled parties.
Medtronic Raises Fiscal 2027 Outlook on Heart Device Surge
Medtronic anticipates higher revenue growth, driven by robust demand for heart devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics achieved a Rs 52.7 crore profit in Q1, a turnaround from last year's loss, fueled by Truenat test-kit demand.
ASHA Workers' Incentives Raised; Andaman Air Ambulance Plans Advance
ASHA workers in Andaman receive a boost as their monthly incentives are increased. Meanwhile, plans for an air ambulance service gain momentum.
Monument Health ICU Permit Boosts Rapid City’s August Valuation
Rapid City achieves record August valuation, driven by Monument Health's new ICU permit.
Amravati NICU Fire: Officials Suspended, Firms Blacklisted After Tragedy
Following the tragic fire at Amravati's NICU, officials and firms face repercussions as investigations continue into the deaths of three newborns.
UK Neonatal Units Review Persistent Pulmonary Hypertension Practices
A new review highlights crucial practices for managing persistent pulmonary hypertension in newborns at UK Level 2 neonatal units.
Medtronic Raises 2027 Forecasts Amid Surge in Heart Device Demand
Medtronic ups 2027 forecasts, driven by heart device demand and strategic investments.
Molbio Diagnostics Achieves Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics reports Rs 52.7 crore profit in Q1, reversing last year's loss, driven by Truenat test-kit sales.
Medtronic Raises Fiscal 2027 Forecasts Amid Surge in Heart Device Demand
Medtronic increases fiscal 2027 revenue projections, driven by strong demand for heart devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in First Quarter Post-IPO
Molbio Diagnostics posts Rs 52.74 crore profit in Q1, a turnaround from last year's loss, driven by Truenat test-kit sales.
Medtronic Raises Revenue Forecasts Amid Heart Device Surge
Medtronic boosts FY 2027 outlook, driven by strong heart device demand and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Following IPO
Molbio Diagnostics posted a Rs 52.7 crore profit in Q1, reversing a loss from last year, driven by robust Truenat test-kit sales.
Medtronic Raises 2027 Forecasts Amid Surge in Heart Device Demand
Medtronic boosts its fiscal 2027 outlook, driven by increased demand for heart devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics reverses previous losses, posting a Rs 52.7 crore profit in Q1 after its IPO.
Medtronic Raises 2027 Forecasts Amid Heart Device Demand Surge
Medtronic has increased its fiscal 2027 forecasts, driven by strong demand for cardiovascular devices and strategic investments in robotics and heart-valve technology.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics, newly listed on August 17, posts Rs 52.74 crore profit in Q1, reversing last year's Rs 23.94 crore loss.
Medtronic Raises Forecasts Amid Surge in Heart Device Demand
Medtronic boosts its fiscal 2027 outlook, driven by a spike in heart device demand, while investing heavily in robotics and heart-valve technology.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1, Reverses Losses
Newly-listed Molbio Diagnostics posted a Rs 52.7 crore profit in Q1, reversing last year's Rs 23.94 crore loss.
Louisiana Legal Battle Could Transform Telehealth Abortion Access
A Louisiana court case is challenging telehealth abortion regulations, potentially reshaping access to reproductive healthcare.
Karpa Health and LegitScript Unite for Telehealth Certification Boost
Karpa Health collaborates with LegitScript to simplify telehealth certification, enhancing compliance for businesses.